Answer
Hemgenix (etranacogene dezaparvovec) should not be used during breastfeeding because excretion into human milk is unknown and a risk to newborns or infants cannot be excluded.
Sources for this answer
- HemgenixCSL Behring UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked